SARAH LEO: Open Payments
NPI 1225397805 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 29 payments from 13 companies in 2025. Trend: 2023 $1,938 · 2024 $1,177 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 3 | $194 |
| Janssen Biotech, Inc. | 4 | $137 |
| IMMUNITYBIO, INC. | 4 | $70 |
| Ferring Pharmaceuticals Inc. | 4 | $67 |
| Alnylam Pharmaceuticals Inc. | 3 | $58 |
| Medtronic, Inc. | 2 | $52 |
| Dendreon Pharmaceuticals LLC | 2 | $50 |
| Boston Scientific Corporation | 1 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
Products named: XIAFLEX, ANKTIVA, RYBREVANT, ERLEADA, ADSTILADRIN, GIVLAARI, PROVENGE, Axonics.
Industry payments across NY — which companies pay providers there.
